A detailed history of Numerai Gp LLC transactions in Pfizer Inc stock. As of the latest transaction made, Numerai Gp LLC holds 12,752 shares of PFE stock, worth $350,169. This represents 0.13% of its overall portfolio holdings.

Number of Shares
12,752
Previous 48,454 73.68%
Holding current value
$350,169
Previous $1.34 Billion 73.46%
% of portfolio
0.13%
Previous 0.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $901,832 - $1.06 Million
-35,702 Reduced 73.68%
12,752 $357 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $1.33 Million - $1.53 Million
-51,446 Reduced 51.5%
48,454 $1.34 Billion
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $2.02 Million - $2.63 Million
77,427 Added 344.53%
99,900 $2.88 Billion
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $811,724 - $939,146
22,473 New
22,473 $824 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Numerai Gp LLC Portfolio

Follow Numerai Gp LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Numerai Gp LLC, based on Form 13F filings with the SEC.

News

Stay updated on Numerai Gp LLC with notifications on news.